Early evidence came from GWAS studies that identified SNPs in upstream Hippo regulators FRMD6 [113] and WWC1 [102, 103] that were associated with AD susceptibility and hippocampal volume changes. This evidence concerns the gene WWC1 and Alzheimer disease.